<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">BJOG</journal-id><journal-id journal-id-type="iso-abbrev">BJOG</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>BJOG : an international journal of obstetrics and gynaecology</journal-title></journal-title-group><issn pub-type="ppub">1470-0328</issn><issn pub-type="epub">1471-0528</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10401611</article-id><article-id pub-id-type="pmcid-ver">PMC10401611.1</article-id><article-id pub-id-type="pmcaid">10401611</article-id><article-id pub-id-type="pmcaiid">10401611</article-id><article-id pub-id-type="manuscript-id">NIHMS1917522</article-id><article-id pub-id-type="pmid">36655360</article-id><article-id pub-id-type="doi">10.1111/1471-0528.17380</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1917522</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1917522</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Maternal Comorbidity and Adverse Perinatal Outcomes in Adolescent and Young Adult Cancer Survivors: a Cohort Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Desai</surname><given-names initials="M">Milli</given-names></name><degrees>MD MAS</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="B">Beth</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nalawade</surname><given-names initials="V">Vinit</given-names></name><degrees>MS</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murphy</surname><given-names initials="J">James</given-names></name><degrees>MD MS</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Veeravalli</surname><given-names initials="N">Nina</given-names></name><degrees>MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Henk</surname><given-names initials="H">Henry</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gyamfi-Bannerman</surname><given-names initials="C">Cynthia</given-names></name><degrees>MD MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Whitcomb</surname><given-names initials="B">Brian</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Su</surname><given-names initials="HI">H. Irene</given-names></name><degrees>MD MSCE</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Obstetrics, Gynecology, and Reproductive Sciences; University of California, San Diego, 3855 Health Sciences Drive, Dept 0901, La Jolla, CA 92093-0901, USA</aff><aff id="A2"><label>2</label>Department of Radiation Medicine and Applied Sciences; University of California, San Diego, La Jolla CA</aff><aff id="A3"><label>3</label>OptumLabs, Minnetonka, MN 55343</aff><aff id="A4"><label>4</label>Department of Biostatistics and Epidemiology; University of Massachusetts, 433 Arnold House, 715 N Pleasant St, Amherst, MA 01003, USA</aff><author-notes><corresp id="CR1"><bold>Co-Corresponding Authors:</bold> H. Irene Su, MD MSCE, Moores UCSD Cancer Center, 3855 Health Sciences Drive, Dept 0901, La Jolla, CA 92093-0901, <email>hisu@health.ucsd.edu</email>, 858-822-5986; Brian Whitcomb, PhD, 433 Arnold House, 715 N Pleasant St, Amherst, MA 01003, <email>bwhitcom@umass.edu</email>, 413-577-7440</corresp><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">Contributed equally</p></fn><fn fn-type="con" id="FN2"><p id="P2">Contribution of authorship</p><p id="P3">Authors contributed to the conception (MD, JM, BW, HIS), planning (MD, BZ, VN, NV, HH, JM, BW, HIS), carrying out (MD, BZ, VN, NV, BW, HIS), analysis (MD, BZ, VN) and writing up (MD, BZ, VN, NV, HH, JM, BW, HIS) of the work.</p></fn><fn fn-type="COI-statement" id="FN3"><p id="P55">Disclosure of interest</p><p id="P56">JM received consulting fees from Boston Consulting Group, HIS received consulting fees from Ferring Pharmaceuticals. The remaining authors report no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>6</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>02</day><month>2</month><year>2023</year></pub-date><volume>130</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">442459</issue-id><fpage>779</fpage><lpage>789</lpage><pub-history><event event-type="nihms-submitted"><date><day>28</day><month>07</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 13:25:13.573"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1917522.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objectives:</title><p id="P4">To evaluate risks of preterm birth (PTB) and severe maternal morbidity (SMM) in female adolescent and young adult cancer survivors and assess maternal comorbidity as a potential mechanism. To determine whether associations differ by use of assisted reproductive technology (ART).</p></sec><sec id="S2"><title>Design:</title><p id="P5">Retrospective cohort</p></sec><sec id="S3"><title>Setting:</title><p id="P6">Commercially insured females in the U.S.</p></sec><sec id="S4"><title>Sample:</title><p id="P7">Female with live births from 2000-2019 within a de-identified U.S. administrative health claims dataset</p></sec><sec id="S5"><title>Methods:</title><p id="P8">Log-binomial regression models estimated relative risks of PTB and SMM by cancer status and tested for effect modification. Causal mediation analysis evaluated the proportions explained by maternal comorbidity.</p></sec><sec id="S6"><title>Main Outcome Measures:</title><p id="P9">SMM, PTB</p></sec><sec id="S7"><title>Results:</title><p id="P10">Among 46,064 cancer survivors, 2,440 singleton births, 214 multiple births, and 2,590 linked newborns occurred after cancer. In singleton births, PTB incidence was 14.8% in cancer survivors versus 12.4% in females without cancer (aRR 1.19, 95%CI 1.06-1.34); SMM incidence was 3.9% in cancer survivors versus 2.4% in females without cancer (aRR1.44, 95%CI 1.13-1.83). Cancer survivors had more maternal comorbidities before and during pregnancy; 26% of the association between cancer and PTB and 30% of the association between cancer and SMM was mediated by maternal comorbidities. Tests for effect modification of cancer status on perinatal outcomes by ART were non-significant.</p></sec><sec id="S8"><title>Conclusion:</title><p id="P11">PTB and SMM risks were modestly increased after cancer. Significant proportions of elevated risks may be due to increased comorbidities. ART did not significantly modify the association between AYA cancer and adverse perinatal outcomes. Prevention and treatment of comorbidities provides an opportunity to improve perinatal outcomes among cancer survivors.</p></sec></abstract><abstract id="ABS2" abstract-type="summary"><title>Tweetable abstract</title><p id="P12">A retrospective cohort study shows increased risks of preterm birth &amp; severe maternal morbidity in young female cancer survivors. Part of risks due to increased maternal comorbidities, informing prevention and screening in AYA cancer survivors.</p></abstract><kwd-group><kwd>Adolescent and young adult cancer</kwd><kwd>maternal comorbidity</kwd><kwd>preterm birth</kwd><kwd>severe maternal morbidity</kwd><kwd>Adolescent and young adult cancer survivors</kwd><kwd>perinatal outcomes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>